Loading
Latest filing published 08 May 2018 for Medite Cancer Diagnostics, Inc., €814k.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Gregory Fortunoff has filed trades across 2 companies (mainly through SEC (Form 4)), most often in American Medical Alert Corp and Medite Cancer Diagnostics, Inc. Over a trading history stretching from 7 June 2006 to 4 April 2018, the count stands at 115 filings.
Purchases make up the whole of the open-market record (85 purchases, €1.1M). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 23 share grants and 1 option exercise. Since January 2018: 1 purchase and no sales on the market.
Half of the purchases are above €2,523 and half below.
The newest entry dates from 8 May 2018: an open-market purchase of €814k, in Medite Cancer Diagnostics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 114 declarations